-
LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
FORBES: BioSante's Pollyannish Press Release
-
With successful conclusion of this Phase III clinical program, LibiGel could be the first product approved by the FDA for women with low sexual desire, HSDD, a significant unmet medical need.
FORBES: BioSante's Pollyannish Press Release
-
Pheromones have been popularized as a factor in sexual desire -- namely, that certain odors that people give off attract potential mates -- but their role in humans is still controversial.
CNN: Sweat may give off stress signals, study says
-
According to a 2008 study published in the Archives of Internal Medicine, between one-third and one-half of all women will find themselves coping with low sexual desire at some point in their lives.
CNN: Are you too tired for sex?
-
After seven pages of analysis by counter-example and refinement, he defines it as an enthusiastic desire, which infuses the body, for sexual activity and its pleasures for their own sake.
ECONOMIST: The deadly sins